TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 216 filers reported holding TG THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $993,488 | -47.7% | 118,856 | +55.4% | 0.00% | -66.7% |
| Q2 2023 | $1,901,346 | +128.2% | 76,483 | +38.7% | 0.00% | +50.0% |
| Q1 2023 | $833,277 | +93.8% | 55,143 | +51.3% | 0.00% | +100.0% |
| Q4 2022 | $430,000 | +140.2% | 36,447 | +19.7% | 0.00% | – |
| Q3 2022 | $179,000 | +26.1% | 30,440 | -8.0% | 0.00% | – |
| Q2 2022 | $142,000 | -56.7% | 33,103 | -3.9% | 0.00% | -100.0% |
| Q1 2022 | $328,000 | -25.6% | 34,433 | +49.5% | 0.00% | 0.0% |
| Q4 2021 | $441,000 | -62.1% | 23,027 | -34.1% | 0.00% | -50.0% |
| Q3 2021 | $1,164,000 | +3.3% | 34,924 | +20.3% | 0.00% | 0.0% |
| Q2 2021 | $1,127,000 | -5.0% | 29,025 | +17.9% | 0.00% | -33.3% |
| Q1 2021 | $1,186,000 | -4.3% | 24,621 | +3.4% | 0.00% | 0.0% |
| Q4 2020 | $1,239,000 | +33.7% | 23,801 | -31.2% | 0.00% | 0.0% |
| Q3 2020 | $927,000 | +104.2% | 34,587 | +48.9% | 0.00% | +50.0% |
| Q2 2020 | $454,000 | +69.4% | 23,231 | -14.4% | 0.00% | +100.0% |
| Q1 2020 | $268,000 | – | 27,143 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,880,323 | $38,633,000 | 2.30% |
| Eversept Partners, LP | 773,501 | $4,343,208 | 1.35% |
| Opaleye Management Inc. | 612,500 | $3,439,000 | 1.24% |
| BRIDGER MANAGEMENT, LLC | 2,334,196 | $13,107,000 | 1.08% |
| Sofinnova Investments, Inc. | 1,733,628 | $9,734,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 354,719 | $1,992,000 | 0.34% |
| 683 Capital Management, LLC | 400,000 | $2,246,000 | 0.25% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 649,460 | $3,646,000 | 0.23% |
| Artal Group S.A. | 900,000 | $5,054,000 | 0.20% |
| Frontier Wealth Management LLC | 226,750 | $1,273,000 | 0.19% |